Company INIFY Laboratories AB

Equities

INIFY

SE0017486103

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Advanced Medical Equipment & Technology

Real-time Oslo Bors Other stock markets 06:21:28 2024-05-13 am EDT			5-day change	1st Jan Change
9.15 ^NOK	-0.54%		-2.66%	-26.21%

2023	Inify Laboratories Launches AI-Powered Cancer Diagnostic Services	MT
2023	Inify Laboratories Announces the Opening of Its First Laboratory	CI

INIFY Laboratories AB is a Sweden-based medical research company that provides cancer diagnostics through laboratory services within pathology. The Company uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customerâs organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The Company origins from ContextVision.

NOK in Million	2022	Weight	2023	Weight	Delta
Cancer Diagnostics 100.0 %	0	nan %	1	100.0 %	-

NOK in Million	2022	Weight	2023	Weight	Delta
Sweden 100.0 %	0	nan %	1	100.0 %	-

Managers	Title	Age	Since
Fredrik Palm CEO	Chief Executive Officer	49	21-11-09
Ann-Charlotte Linderoth DFI	Director of Finance/CFO	52	21-12-31
Arto Järvinen CTO	Chief Tech/Sci/R&D Officer	65	21-12-31
Anders Claes-Göran Lindh CTO	Chief Tech/Sci/R&D Officer	45	22-08-31
Emelie Edvigsson PRN	Corporate Officer/Principal	-	21-12-31
Sven Magnus Aurell PRN	Corporate Officer/Principal	60	-
Johanna Karling LAW	General Counsel	61	22-01-31

Members of the board	Title	Age	Since
Lars Olof Sandèn CHM	Chairman	62	21-11-09
Magne Jordanger BRD	Director/Board Member	71	22-04-30
Knut Martin Henschen Ingvar BRD	Director/Board Member	69	21-11-09

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	45,236,750	6,345,658 ( 14.03 %)	0	14.03 %

Name	Equities	%	Valuation
Gallivant SARL 60.09 %	27,181,386	60.09 %	23 M kr
Tauri AS 10.37 %	4,691,412	10.37 %	4 M kr
Danske Bank A/S (Investment Management Sweden) 4.530 %	2,049,106	4.530 %	2 M kr
Sven Günther-Hanssen 4.343 %	1,964,768	4.343 %	2 M kr
MP Pensjon PK 3.033 %	1,372,243	3.033 %	1 M kr
Bras Holding AS 2.211 %	1,000,151	2.211 %	862 500 kr
Monsun AS 2.182 %	986,950	2.182 %	851 116 kr
Bernt Stavland 1.555 %	703,304	1.555 %	606 508 kr
Anders J Stavland 1.433 %	648,167	1.433 %	558 960 kr
Per Stavland 0.9413 %	425,800	0.9413 %	367 197 kr

INIFY Laboratories AB

Scheeles väg 3

171 65, Solna

+46 08 26 73 30

http://www.inify.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INIFY LABORATORIES AB	-26.21%	38.37M
THERMO FISHER SCIENTIFIC	+11.73%	226B
DANAHER CORPORATION	+9.53%	188B
INTUITIVE SURGICAL, INC.	+14.63%	137B
BOSTON SCIENTIFIC CORPORATION	+27.47%	108B
SIEMENS HEALTHINEERS AG	+0.08%	63.19B
EDWARDS LIFESCIENCES CORPORATION	+13.73%	52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	51B
AGILENT TECHNOLOGIES, INC.	+7.72%	43.89B
GE HEALTHCARE TECHNOLOGIES INC.	+7.86%	38.07B

Other Advanced Medical Equipment & Technology